...

DAFTAR PUSTAKA 1. Abdurachman. 2. Akbar. N., 2002.

by user

on
Category:

annual report

1

views

Report

Comments

Transcript

DAFTAR PUSTAKA 1. Abdurachman. 2. Akbar. N., 2002.
DAFTAR PUSTAKA
1. Abdurachman. S. A., 2002. Hepatitis Virus Kronik. Dalam: Noer. S, editor:
Ilmu Penyakit Dalam. Jilid 1. Edisi 3. Jakarta: Gaya Baru. Hal 262-70
2. Akbar. N., 2002. Kelainan Enzim pada Penyakit Hati. Dalam: Noer. S,
editor: Ilmu Penyakit Dalam. Jilid 1. Edisi 3. Jakarta: Gaya Baru. Hal
238-42
3. Biron. C. A., Sen. G. c., 2000.
FundamentalVirology
Interferons and other cytokines.
4. Boinot. J. K., Wu. T. T., 1996. Liver and Gallbladder. In: Epstein. J. 1.,
editors: Surgical Pathology CD-Room. John Hopkins University Press
5. Bratawidjadja. K. G., 2001. Imunologi Dasar. Edisi 4. Jakarta: Gaya Barn.
Hal. 9,249
6. Brooks. G. F., Butel. J. S., Morse. S. A., Jawetz. E., Melnick. J. L.,
Adelberg. E. A., 2001. Medical Microbiology. 22nded. Philadelphia:
Appleton & Lange. P.403-17
7. Chow. W. C. et ai, 1998. Re-treatment with interferon alfa of patients with
chronic hepatitis C (abstract). 1. Hepatology 4(27): 1144 - 8
8. Chung. R. T., Podolsky. D. K., 2001. Cirrhosis and its complications. In:
Braunwald. E., et aI, editors: Harisson's Principle of Internal Medicine
CD Room, 15Thed. The McGraw-Hill Medical Publishing Division
9. Collier. L., Oxford. J., Pipkin. J., 2000. Human Virology. 2nd ed. London:
Oxford University Press. P. 169-70
10. Crawford. J. .M., 1999. The Liver and The Biliary Tract. In: Cotrans RS.,
Kumar V., Collins T., editors: Robbin's Pathologic Basis of Diseasse. 6th
ed. Philadelphia: W.B. Saunders Company. P. 846-61
11. Dianzani. F., Baron. S., 2000. Nonspecific defenses.
http://www.gsbs.utmb.edulmicrobook/ch049.html
Available from:
12. Dienstag. J. L., Isselbacher. K. J., 2001. Acute Viral Hepatitis. In:
Braunwald. E., et aI, editors: Harisson's Principle of Internal Medicine
CD Room, 15Thed. The McGraw-Hill Medical Publishing Division
82
83
13. Dienstag. J. L., Isselbacher. K J., 2001. Chronic Hepatitis. In: Braunwaid.
E., et aI, editor: Harisson's Principle of Internal Medicine CD Room,
15Thed. The McGraw-Hill Medical Publishing Division
14. Fargion. et ai, 2003. Peginterferon alfa-2a (40kd) (Pegasys) plus ribavirin
(RBV) and amantadine (AMA) vs inductions therapy with interferon
alfa-2a (Roferon-A) plus RBV and AMA in IFN/RBV nonresponders
patients with chronic hepatitis C (CHC) (abstract). Available from:
http://www.hivandhepatitis.com/2003 icr/38easl/ docs/03 2J03d.html
15. Fried. M. W. et ai, 2002. Peginterferon alfa-2a plus ribavirin for chronic
hepatitis C virus infections (abstract). N Engl J Med, 347 (13): 975-82..
Available from: http://content.nejm.orglcgilcontent/short/347 / J3/975
16. Hadi S, 1999. Gastroenterologi. Edisi 7. Bandung: Penerbit Alumni. Hal
517-26
17. Hasan. A., 2002. Pengobatan Hepatitis Kronik dengan Interferon. Dalam:
Noer. S., editor: Ilmu Penyakit Dalam. Jilid 1. Edisi 3. Jakarta: Gaya
Baru. Hal: 317-22
18. Hepatitis factsheet, 2003. Interferons. Available from:
http://www.hepcvets.com/drug/interferons. html
19. Husada. Y., 2002. Fisiologi dan Pemeriksaan Biokimiawi Hati. Dalam:
Noer. S., editor: Ilmu Penyakit Dalam. Jilid 1. Edisi 3. Jakarta: Gaya
Baru. Hal 224-30
20. Iqbal. M., 2002. An update on the management of hepatitis C. Available
from: http://hepcvets.com/hepclupdate. html
21. Koff. R. S., 1998. Chronic Hepatitis C. The McGraw-Hill Companies.
Available from: http://www.hosppract.com/issues/J998/06Icekoff.htm
22. Mangia. A., 2003. A randomised controlled trial on pegylated interferon alfa2a (40KD) (Pegasys) or IFN alfa-2a (Roferon-A) plus ribavirin (RBV)
and amantadine (AMA) vs IFN alfa-2a and RBV in naive patients with
chronic HCV). Available from:
http://www.hivandhepatitis.com/2003 icr/38easl/ docs/03 2J03a.html
23. Manns. M. P., 1998. A new approach to HCV therapy. Available from:
http://www.hepnet.com/hepcluldh98/manns.html
24. Macroscopic Lever on Chronic Hepatitis C, 1998. Available from:
http://www.medlib.med. Utah.edwwebPathiliveHTML/liver082. html
84
25. Minunk. G., Assy. N., 1999. Consequences of chronic hepatitis C. Available
from: http://www.hepnet.comlupdate2.html
26. Nairn. R., Helbert. M., 2002. Immunology for Medical Students. London:
Mosby International Ltd. Hal. 158-60
27. Simon. S., 2002. Berbagai aspek diagnostik hepatitis C. Jurnal Kedokteran
Atma Jaya. 2(1): 127 - 40
28. Simon. S., Ali. S., 2002.
Peranan biologi molekuler dalam menegakan
diagnosishepatitis virus. Jurnal KedokteranAtma Jaya, 1(1) : 83 - 91
29. Stites. D. P., Terr. A. I., Parslow. P. G., 1997. Medical Imunology. 9th ed.
Philadelphia: Appleton & Lange. Hal. 157-58
30. Sulaiman. A., 2002. Terapi standar mutakhir untuk hepatitis C kronik.
Available from:
http://wwwpapdi.or.idlPanduanlPanduan%20II%20terapi ~standar ~mut
akhir untuk he.htm
~
~
31. Sulkowski. M., 2002. Pegylated interferon in the treatment of patients with
hepatitis C. Available from: http://www.numedx.com/readstory.html
32. Tarigan. P., 2002. Sirosis Hati. Dalam: Noer. S, editor: Ilmu Penyakit
Dalam. Jilid 1. Edisi 3. Jakarta: Gaya Baru. Hal: 271-79
33. The Cancer BACUP Factsheet. 2000. History of interferon.
from: http://www.cancerbacup.org. uk!
Available
34. Tortora. G. .J., Funke. B. R., Case. C. L., 2001. Microbiology an
introduction. 7Thed. Toronto:Benjamin Cummings. Hal. 469-72
35. Thornton. A., Honeywell. M., Hollis. A. L., Thomson. M., 2002. Update on
hepatitis C virus. Available from:
http://www.uspharmacist.comlindex.asp ?show=ce
36. USP Disspensing Information, 2001. USP [email protected] Drug Information for The
Health Care Professional CD Room. Englewood. Micromidex, Inc.
37. Widjaja. S., 1999. Virus Hepatitis B, C, dan G. Jakarta: PT. Gramedia. Hal
21-35
38. Widjaja. S., Simon. S., Ali. S., 2002.
Kedokteran Atma Jaya, 1(1) : 39-50
Hepatitis C up date.
Jurnal
85
39. Widura, 2000. Interferon sebagai pengendali proliferasi sel. Majalah J/miah
Kedokteran Maranatha, 6( 17): 70-6
40. Wilson L.M., Lester L.B., 1992. Hati, Saluran Empedu, dan Pangkreas.
Oalam : Price S.A., Wilson L.M, editors: Patofisiologi Konsep Klinik
Proses-proses Penyakit. Edisi 4. Jakarta: Penerbit Buku Kedokteran
EGC. Hal. 439-40, 442-5
41. World Health Organization, 2000. Global Chronic Hepatitis C Infections.
Available from: http://www.idenix.com/hcv/hcv-overview. html
42. Zhang. F., 2003. Pegylated Interferons in the treatment of chronic hepatitis C
(abstract). Chin Med J (Engl), 116 (4) : 495 - 8. Available from:
http://cmbi.bjmu. edu.cniChinaPaper/details.asp?PubMedID= 12875709
--
------
Fly UP